StockNews.com began coverage on shares of BiondVax Pharmaceuticals (NASDAQ:BVXV – Free Report) in a report issued on Monday morning. The firm issued a hold rating on the stock. BiondVax Pharmaceuticals Price Performance BiondVax Pharmaceuticals has a fifty-two week low of $1.25 and a fifty-two week high of $11.80. The stock has a 50-day simple moving […]
StockNews.com assumed coverage on shares of BiondVax Pharmaceuticals (NASDAQ:BVXV – Free Report) in a research note published on Sunday morning. The firm issued a hold rating on the stock. BiondVax Pharmaceuticals Price Performance The firm has a 50-day moving average of $1.36 and a 200-day moving average of $1.69. The stock has a market cap […]
StockNews.com started coverage on shares of BiondVax Pharmaceuticals (NASDAQ:BVXV – Free Report) in a research note issued to investors on Friday morning. The firm issued a hold rating on the stock. BiondVax Pharmaceuticals Price Performance NASDAQ BVXV opened at $1.36 on Friday. BiondVax Pharmaceuticals has a 1 year low of $1.25 and a 1 year […]
StockNews.com assumed coverage on shares of BiondVax Pharmaceuticals (NASDAQ:BVXV – Free Report) in a report issued on Wednesday. The brokerage issued a hold rating on the stock. BiondVax Pharmaceuticals Price Performance Shares of BVXV opened at $1.32 on Wednesday. BiondVax Pharmaceuticals has a 12-month low of $1.25 and a 12-month high of $11.80. The firm […]
StockNews.com started coverage on shares of BiondVax Pharmaceuticals (NASDAQ:BVXV – Free Report) in a report published on Saturday. The brokerage issued a hold rating on the stock. BiondVax Pharmaceuticals Price Performance Shares of BVXV stock opened at $1.39 on Friday. The company has a market cap of $2.60 million, a PE ratio of -0.39 and […]